Southern Acids (M)

SAB

MYL5134OO001

Commodity Chemicals

End-of-day quote BURSA MALAYSIA Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
3.55 ^MYR	-3.01%		-3.53%	+12.70%

30/05	Southern Acids (M) Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
30/05	Southern Acids (M) Berhad Proposes Single Tier Final Dividend for the Financial Year Ended 31 March 2024	CI

Southern Acids (M) Berhad Announces Appointment of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Independent and Non Executive Ember of Audit Committee

November 26, 2020 at 06:17 pm IST

Southern Acids (M) Berhad announced appointment of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Independent and Non Executive ember of Audit Committee. Date of change is November 26, 2020.

Latest news about Southern Acids (M)

Southern Acids (M) Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	30/05	CI
Southern Acids (M) Berhad Proposes Single Tier Final Dividend for the Financial Year Ended 31 March 2024	30/05	CI
Southern Acids (M) Berhad Announces Production Results for the Month of March 2024	08/04	CI
Southern Acids (M) Berhad Announces Redesignation of Chung Kin Mun from Independent Director to Non Independent and Non Executive Director	20/03	CI
Southern Acids (M) Berhad Announces Production Results for the Month of February 2024	11/03	CI
Southern Acids (M) Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	29/02	CI
Southern Acids (M) Berhad Announces Redesignation of Stephen Wan Yeng Leong from Member of Audit Committee to Independent and Non Executive Chairman of Audit Committee	29/02	CI
Southern Acids (M) Berhad Announces Cessation of Office of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Independent and Non Executive Member of Audit Committee	29/02	CI
Southern Acids (M) Berhad Announces Redesignation of Chung Kin Mun from Chairman of Audit Committee to Independent and Non Executive Member of Audit Committee	29/02	CI
Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Independent and Non Executive Member of Audit Committee	29/02	CI
Southern Acids (M) Berhad Reports Production Results for the Month of January 2024	08/02	CI
Southern Acids (M) Berhad Reports Production Results for the Month of December 2023	08/01	CI
Southern Acids (M) Berhad Reports Production Results for the Month of November 2023	08/12	CI
Southern Acids (M) Berhad Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	28/11	CI
Southern Acids (M) Berhad Reports Production Results for the Month of October 2023	10/11	CI
Southern Acids (M) Berhad Reports Production Results for the Month of September 2023	09/23/09	CI
Southern Acids (M) Berhad Reports Production Results for the Month of August 2023	11/23/11	CI
Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Independent and Non Executive Director	30/23/30	CI
Southern Acids' Profit Declines in Fiscal Q1	30/23/30	MT
Southern Acids (M) Berhad Reports Property, Plant and Equipment Written Off for the First Quarter Ended June 30, 2023	29/23/29	CI
Southern Acids (M) Berhad Reports Earnings Results for the First Quarter Ended June 30, 2023	29/23/29	CI
Southern Acids (M) Berhad Reports Production Results for the Month of July 2023	09/23/09	CI
Southern Acids (M) Berhad Proposes Single Tier Final Dividend for the Financial Year Ended 31 March 2023, Payable on 4 October 2023	28/23/28	CI
Southern Acids (M) Berhad Reports Production Results for the Month of June 2023	11/23/11	CI
Southern Acids to Seek Shareholder Nod to Renew Buyback, Transaction Authority	07/23/07	MT

Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products. The Company operates through three segments: Oleochemical, Milling & Estate, and Healthcare. The Oleochemical segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The manufacturing plant is located in Kapar, Klang, which has an annual manufacturing capacity of approximately 100,000 metric tons (MT). The Milling & Estate Segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (POM) and palm kernel, as well as oil palm cultivation. It operates two POM located in Riau, Indonesia with a combined milling capacity of 100 MT per hour. The Healthcare Segment operates Sri Kota Specialist Medical Centre (Sri Kota), a 232-bedded private tertiary hospital located in Klang, Selangor.

Sector

Commodity Chemicals

Calendar

27/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Commodity Chemicals

	1st Jan change	Capi.
SOUTHERN ACIDS (M)	+12.70%	10Cr
AIR LIQUIDE	+3.74%	10TCr
SABIC	-6.95%	6.21TCr
PT CHANDRA ASRI PACIFIC TBK	+75.24%	4.9TCr
WANHUA CHEMICAL GROUP CO., LTD.	+13.54%	3.78TCr
LYONDELLBASELL INDUSTRIES N.V.	+0.44%	3.11TCr
WESTLAKE CORPORATION	+11.92%	2.01TCr
NINGXIA BAOFENG ENERGY GROUP CO., LTD.	+10.77%	1.65TCr
HENGLI PETROCHEMICAL CO.,LTD.	+8.20%	1.39TCr
RONGSHENG PETROCHEMICAL CO., LTD.	-4.15%	1.31TCr